Benzimidazole drugs and modulation of biotransformation enzymes

被引:194
作者
Velík, J
Baliharová, V
Fink-Gremmels, J
Bull, S
Lamka, J
Skálová, L
机构
[1] Charles Univ Prague, Fac Pharm, Res Ctr LN00B125, Dept Pharmacol & Toxicol, CZ-50005 Hradec Kralove, Czech Republic
[2] Charles Univ Prague, Fac Pharm, Res Ctr LN00B125, Dept Biochem Sci, CZ-50005 Hradec Kralove, Czech Republic
[3] Univ Utrecht, Div Vet Pharm Pharm & Toxicol, Utrecht, Netherlands
关键词
benzimidazole; cytochrome P450; enzyme induction; enzyme inhibition; anthelmintic; proton pump inhibitors;
D O I
10.1016/j.rvsc.2003.08.005
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Benzimidazole drugs (e.g., anthelmintics albendazole, fenbendazole, oxfenbendazole, thiabendazole, mebendazole; inhibitors of proton pump omeprazole, lansoprasole, pantoprasole) represent substances used in both human and veterinary medicine; however, from the point of view of induction and inhibition of biotransformation enzymes, research has been carried out mainly due to the initiative of human pharmacologists. The purpose of the present review is to inform about inductive and inhibitive effects of benzimidazole drugs in man, animals and cell cultures. Pharmacological and toxicological consequences of modulation of biotransformation enzymes are discussed and the significance of studies in the field of modulation of biotransformation enzymes in food-producing animals is explained. Since the modulating effect of benzimidazoles strongly varies depending on structure of the individual substances, the particular attention is paid to structure-modulation relationships. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:95 / 108
页数:14
相关论文
共 116 条
[61]   Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog [J].
Lu, C ;
Li, AP .
CHEMICO-BIOLOGICAL INTERACTIONS, 2001, 134 (03) :271-281
[62]   PHARMACOKINETICS OF ALBENDAZOLE IN MAN [J].
MARRINER, SE ;
MORRIS, DL ;
DICKSON, B ;
BOGAN, JA .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (06) :705-708
[63]  
MARRINER SE, 1980, AM J VET RES, V41, P1126
[64]   Effects of proton pump inhibitors on thyroid hormone metabolism in rats - A comparison of UDP-glucuronyltransferase induction [J].
Masubuchi, N ;
Hakusui, H ;
Okazaki, O .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (11) :1225-1231
[65]   An evaluation of the CYP1A induction potential of pantoprazole in primary rat hepatocytes: a comparison with other proton pump inhibitors [J].
Masubuchi, N ;
Okazaki, O .
CHEMICO-BIOLOGICAL INTERACTIONS, 1997, 107 (1-2) :63-74
[66]  
Masubuchi N, 1997, DRUG METAB DISPOS, V25, P584
[67]  
Masuda A, 1998, ADV EXP MED BIOL, V450, P1
[68]   EXPERIMENTAL AND THEORETICAL-STUDIES OF ALBENDAZOLE, OXIBENDAZOLE, AND TIOXIDAZOLE [J].
MCCRACKEN, RO ;
LIPKOWITZ, KB .
JOURNAL OF PARASITOLOGY, 1990, 76 (02) :180-185
[69]   INDUCTION OF CYTOCHROME-P450IA GENES (CYP1A) BY OMEPRAZOLE IN THE HUMAN ALIMENTARY-TRACT [J].
MCDONNELL, WM ;
SCHEIMAN, JM ;
TRABER, PG .
GASTROENTEROLOGY, 1992, 103 (05) :1509-1516
[70]   Fenbendazole pharmacokinetics, metabolism, and potentiation in horses [J].
McKellar, QA ;
Gokbulut, C ;
Muzandu, K ;
Benchaoui, H .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (11) :1230-1239